The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 17, 2020
Filed:
Jun. 24, 2011
Applicants:
Pier Adelchi Ruffini, Milan, IT;
Bjarne Bogen, Snaroya, NO;
Agnete Brunsvik Fredriksen, Raelingen, NO;
Inventors:
Pier Adelchi Ruffini, Milan, IT;
Bjarne Bogen, Snaroya, NO;
Agnete Brunsvik Fredriksen, Raelingen, NO;
Assignee:
VACCIBODY AS, Oslo, NO;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01); C07K 16/44 (2006.01); A61K 39/145 (2006.01); A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 39/0011 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); C07K 16/44 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/6056 (2013.01); C07K 2317/526 (2013.01); C07K 2317/53 (2013.01); C07K 2317/622 (2013.01); C07K 2317/64 (2013.01); C07K 2319/30 (2013.01); C07K 2319/33 (2013.01); C07K 2319/40 (2013.01); C07K 2319/42 (2013.01); C12N 2760/16111 (2013.01); C12N 2760/16134 (2013.01);
Abstract
The present disclosure relates to recombinant fusion proteins, such as human antibody-based molecules called Vaccibodies, which are able to trigger both a T cell- and B cell immune response. The present disclosure also relates to a method of treating a cancer or an infectious disease by means of these specific fusion proteins.